More about

Dermatitis

News
March 26, 2024
1 min read
Save

ChatGPT may potentially improve patch testing efficiency for allergic contact dermatitis

ChatGPT may potentially improve patch testing efficiency for allergic contact dermatitis

SAN DIEGO — While it did not perform at the level of clinicians, ChatGPT could be used as a tool to improve patch testing efficiency for allergic contact dermatitis, according to a poster presentation here.

News
March 19, 2024
2 min read
Save

Lebrikizumab shows early efficacy in atopic dermatitis for patients with skin of color

Lebrikizumab shows early efficacy in atopic dermatitis for patients with skin of color

SAN DIEGO — Atopic dermatitis improvement was found with lebrikizumab treatment in patients with skin of color, according to interim study results presented at the American Academy of Dermatology Annual Meeting.

News
March 14, 2024
2 min read
Save

Nemolizumab shows long-term efficacy in treatment of prurigo nodularis, atopic dermatitis

Nemolizumab shows long-term efficacy in treatment of prurigo nodularis, atopic dermatitis

SAN DIEGO — At the American Academy of Dermatology Annual Meeting, Galderma announced new data demonstrating nemolizumab’s long-term efficacy in treating prurigo nodularis and atopic dermatitis, according to a press release.

News
March 12, 2024
3 min read
Save

Roflumilast improves atopic dermatitis symptoms in children aged 2 to 5 years

Roflumilast improves atopic dermatitis symptoms in children aged 2 to 5 years

SAN DIEGO — In children aged 2 to 5 years with atopic dermatitis, roflumilast cream 0.05% significantly improved symptoms compared with vehicle, with improvement seen as early as 1 week after treatment, according to a speaker here.

News
March 09, 2024
2 min read
Save

Vtama cream achieves consistent efficacy in atopic dermatitis across racial groups

Vtama cream achieves consistent efficacy in atopic dermatitis across racial groups

SAN DIEGO — New data showed Vtama cream achieved consistent and strong efficacy for the treatment of atopic dermatitis across all racial groups, according to a poster presentation at the 2024 American Academy of Dermatology Annual Meeting.

News
March 03, 2024
1 min read
Save

Skin microbiota predicts atopic dermatitis in infants

Skin microbiota predicts atopic dermatitis in infants

WASHINGTON — Atopic dermatitis can be predicted in children aged as young as 6 months with skin microbiome and metabolome signatures, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

News
February 29, 2024
1 min read
Save

Patients with atopic dermatitis maintain improvements for up to 2 years with lebrikizumab

Patients with atopic dermatitis maintain improvements for up to 2 years with lebrikizumab

WASHINGTON — Patients with moderate to severe atopic dermatitis treated with lebrikizumab maintained improvements in patient-reported outcomes, according to a poster presented here.

News
February 29, 2024
2 min read
Save

Liquid synthetic detergents may be better cleansers for patients with atopic dermatitis

Liquid synthetic detergents may be better cleansers for patients with atopic dermatitis

WASHINGTON — Patients with atopic dermatitis may have better outcomes when using liquid synthetic detergents, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

News
February 25, 2024
1 min read
Save

Early non-lesional filaggrin expression predicts childhood asthma in atopic dermatitis

Early non-lesional filaggrin expression predicts childhood asthma in atopic dermatitis

WASHINGTON — Among children with atopic dermatitis, low non-lesional skin filaggrin expression during early ages predicted future asthma, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

News
February 21, 2024
2 min read
Save

Plant-based topical successfully targets both inflammation, bacteria in atopic dermatitis

Plant-based topical successfully targets both inflammation, bacteria in atopic dermatitis

MIAMI BEACH, Fla. — Zabalafin, a nonsteroidal topical, demonstrated efficacy in reducing inflammation and bacteria on the skin of children and adults with atopic dermatitis, according to interim data presented in a poster at Masters of Pediatric Dermatology.

View more